Biphasic effects of dopamine on 86rubidium uptake in rat renal proximal tubules

Clin Exp Hypertens. 2000 Apr;22(3):289-301. doi: 10.1081/ceh-100100078.

Abstract

The mechanism(s) by which dopamine inhibits Na+-K+-ATPase activity in the renal proximal tubule is still controversial. We studied the short-term effects of dopamine on the sodium pump in rat renal proximal tubule suspensions with the 86Rb uptake method. Dopamine and the D1-like agonist, SKF81297, initially stimulated Na+-K+-ATPase activity at 5 min and subsequently inhibited it at 10 min and 20 min; the inhibition by 10 microM dopamine at 20 min was 21.3 +/- 4.5%. The inhibitory effect of dopamine on Na+-K+-ATPase activity was mimicked by thymeleatoxin (a classical protein kinase C [PKC] agonist) while Sp-8-CPT-cAMPS (a protein kinase A [PKA] agonist) had no effect. However, the combination of the PKC and PKA agonists mimicked the biphasic effects of dopamine and SKF81297. Rp-8-CPT-cAMPS (a PKA inhibitor), U-73122 (a phospholipase C inhibitor), or calphostin C (a PKC inhibitor), blocked the dopamine-mediated biphasic effects on Na+-K+-ATPase activity. It is suggested that the biphasic effects of dopamine on Na+-K+-ATPase activity (an initial stimulation and a subsequent inhibition) are transduced by activating both PKA and PKC through a D1-like receptor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzazepines / pharmacology
  • Cardiotonic Agents / pharmacology*
  • Collagenases / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / drug effects
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dopamine / pharmacology*
  • Dopamine Agonists / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Ion Transport / drug effects
  • Kidney Tubules, Proximal / diagnostic imaging
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism*
  • Male
  • Phorbol Esters / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Protein Kinase C / drug effects
  • Protein Kinase C / metabolism
  • Pyrrolidinones / pharmacology
  • Radionuclide Imaging
  • Rats
  • Rats, Inbred WKY
  • Rubidium Radioisotopes / pharmacokinetics*
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Sodium-Potassium-Exchanging ATPase / drug effects
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Thionucleotides / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Benzazepines
  • Cardiotonic Agents
  • Dopamine Agonists
  • Enzyme Inhibitors
  • Estrenes
  • Phorbol Esters
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • Rubidium Radioisotopes
  • Thionucleotides
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • adenosine-3',5'-cyclic phosphorothioate
  • SK&F 81297
  • thymeleatoxin
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Type C Phospholipases
  • Collagenases
  • Sodium-Potassium-Exchanging ATPase
  • Dopamine